Advanced Proteome Therapeutics Corporation V.APC.H

HDL Video

[jmostock]

This is interesting, CEO of HeidleBerg On Oct 17, 2018:

https://ca.proactiveinvestors.com/companies/stocktube/10893/heidelberg-pharma-looks-to-file-ind-q2-2019-for-its-drug-to-treat-cancer-tumors-10893.html

This is very realevant and in my eyes shows me that HDL is a competitor to APC with a differentiator of "we have a Drug too Amanitin" on top of our linker tech.        

APC released it's basic update of we did great in our tests - Oct 15th.     APC also wants license out their technology.   So the same model as HDL.   

So again, maybe APC's linker is better than HDL Linker.    This could very well be the reason for a delayed news release.   Negotiations could be happening in the background on how the relationship will work going forward.   Seems to me, HDL would need APC more than we need HDL, if we had cash.